Aarti Drugs share news, announcements and annual reports
NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap
Aarti Drugs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1993 on BSE, Sep 2003 on NSE
Last close ₹435.20down ₹13.80 (3.07%)BSE ₹435.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹449.00.
30 Oct: open ₹444.00, high ₹449.00, low ₹432.50
52-week range of traded prices to 30 Oct 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,972 Cr930th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.46%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.37
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,91,56330.3% delivered
Aarti Drugs board meetings
113 filed, newest first. Page 3 of 3.
May 2009
11 May · Board meeting
To transact, inter alia, the following business: [1] To consider and take on record the Audited Financial Results for the quarter and year ended March 31, 2009; [2] To consider recommendation of dividend, if any.
Jan 2009
13 Jan · Board meeting
Company had informed the Exchange regarding the Board Meeting to be held on January 28, 2009 inter alia to consider and take on record audited financial results of the Company for the quarter ended December 31, 2008. The Company has now informed the Exchange that the date of the said Board meeting has now been changed to January 29, 2009 instead of January 28, 2009 inter alia to consider, approve and take on record the audited financial results of the Company for the quarter & nine months ended on December 31, 2008.10 Jan · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter & nine months ended on December 31, 2008.
Oct 2008
7 Oct · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter & half year ended on September 30, 2008.
Jul 2008
18 Jul · Board meeting
To transact, interalia, the following business : 1) To consider and take on record the Audited Financial Results for the quarter ended June 30, 2008.
May 2008
5 May · Board meeting
To transact the following business: (1) To consider and take on record the Audited Financial Results for the quarter and the year ended March 31, 2008. (2) To consider recommendation of final dividend, if any.
Jan 2008
14 Jan · Board meeting
To transact the following business: 1) To consider and take on record Audited Financial Results for the quarter ended December 31, 2007.
Oct 2007
18 Oct · Board meeting
To consider and take on record Audited Financial Results for the quarter and half year ended September 30, 2007.
Jul 2007
21 Jul · Board meeting
To consider and take on record Audited Financial Results for the quarter ended June 30, 2007.
May 2007
18 May · Board meeting
Aarti Drugs Ltd. has informed the Exchange that "the Board of Directors in their meeting held on May 18, 2007 have not recommended any final dividend and the Interim dividend of Rs.1.20 ps. (12%) per share on 1,17,08,550 Equity Shares of Rs.10/- each fully paid up already declared and paid by the Company in March 2007 is confirmed as final dividend for the financial year 2006-07".7 May · Board meeting
To transact the following business: 1) To consider and take on record Audited Financial Results for the quarter and the year ended March 31, 2007. 2) To consider recommendation of final dividend, if any.
Mar 2007
5 Mar · Board meeting
To consider inter alia, declaration of 1st Interim dividend, if any, on the Equity Shares of the Company for the financial year ending March 31, 2007. The company has further informed the Exchange that March 21, 2007 has been fixed as the Record Date for the purpose of payment of 1st Interim Dividend on Equity Shares if any, declared. In case of approval of 1st Interim dividend by the Board of Directors, the Company shall commence despatch of dividend warrants on and from March 23, 2007.
Jan 2007
15 Jan · Board meeting
Inter-alia to consider and take on record audited financial results for the quarter ended on December 31, 2006.